Companies: 10,795·Total market cap: $144.5T
Innovation Pharmaceuticals Inc.

Innovation Pharmaceuticals Inc.

IPIXOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$155504
P/E Ratio—
52W High$0.05
52W Low$0.00001
Overview

Innovation Pharmaceuticals Inc. (IPIX) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001355250 · IPIX · OTC · as of Jun 9, 2026

Filing snapshot

304
Total Filings
8-K
Latest Form
2024-02-01
Most Recent
2007
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001355250 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2023-09-28
Fiscal Year End
Sep 28, 2023
Accession No.
0001477932-23-007158
Primary Document
ipix_10k.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001355250 · Accession 0001477932-23-007158

Latest Key Filings

10-QQuarterly Report
FORM 10-Q
2023-11-20
View 10-Q on SEC
8-KCurrent Report
FORM 8-K
2024-02-01Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
8-KCurrent Report
FORM 8-K
2024-02-01
View
8-KCurrent Report
FORM 8-K
2023-12-05
View
10-QQuarterly Report
FORM 10-Q
2023-11-20
View
NT 10-QNT 10-Q
NT 10-Q
2023-11-15
View
8-KCurrent Report
FORM 8-K
2023-10-30
View
10-KAnnual Report
FORM 10-K
2023-09-28
View
10-QQuarterly Report
FORM 10-Q
2023-05-15
View
10-QQuarterly Report
FORM 10-Q
2023-02-15
View
NT 10-QNT 10-Q
NT 10-Q
2023-02-15
View
8-KCurrent Report
FORM 8-K
2023-01-04
View
10-QQuarterly Report
FORM 10-Q
2022-11-10
View
10-KAnnual Report
FORM 10-K
2022-09-28
View
SC 13G/ABeneficial Ownership Report (Amended)
AMENDMENT NO. 2 TO SCHEDULE 13G
2022-07-05
View
8-KCurrent Report
FORM 8-K
2022-06-15
View
10-QQuarterly Report
FORM 10-Q
2022-05-13
View
Showing 1–15 of 278 filingsForm 4 / 144 hidden· 304 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001355250  |  Exchange: OTC · Healthcare

Innovation Pharmaceuticals Inc. (OTC: IPIX) has submitted 304 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2007. As a Healthcare sector company with CIK 0001355250, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Innovation Pharmaceuticals Inc.'s most comprehensive regulatory disclosure. The most recent Innovation Pharmaceuticals Inc. 10-K was filed on 2023-09-28 for fiscal year ending 2023. Historical IPIX 10-K annual reports are available from 2006 through 2023.

Investors researching Innovation Pharmaceuticals Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-09
Related Companies SEC Filings — Healthcare
RSPI SEC Filings →CHNXF SEC Filings →VIRX SEC Filings →RASP SEC Filings →WSNAF SEC Filings →MDIN SEC Filings →NBIO SEC Filings →LFCOF SEC Filings →
→ IPIX Financials→ IPIX Earnings→ IPIX Insider Trades

Frequently Asked Questions

IPIX SEC Filings · 8 questions

Innovation Pharmaceuticals Inc. (IPIX) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 304 filings and access original documents at no cost. Innovation Pharmaceuticals Inc.'s CIK is 0001355250.

IPIX SEC filingsInnovation Pharmaceuticals Inc. SEC documentsfind IPIX 10-K